Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis

  Free Subscription


24.05.2021

1 BMJ
1 Clin Infect Dis
1 Dig Dis Sci
2 Hepatology
1 J Clin Gastroenterol
1 J Infect Dis
9 J Viral Hepat
2 PLoS One
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMJ

  1. MEHTA SJ, Day SC, Norris AH, Sung J, et al
    Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    BMJ. 2021;373:n1022.
    PubMed         Abstract available


    Clin Infect Dis

  2. BOEKE CE, Hiebert L, Waked I, Tsertsvadze T, et al
    Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes from National Treatment Programs in Three Low- and Middle-Income Countries.
    Clin Infect Dis. 2021 May 20. pii: 6279051. doi: 10.1093.
    PubMed         Abstract available


    Dig Dis Sci

  3. LIN MH, Li HQ, Zhu L, Su HY, et al
    Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
    PubMed         Abstract available


    Hepatology

  4. MESZAROS M, Truchi R, Ouzan D, Tran A, et al
    Sofosbuvir, glecaprevir, pibrentasvir, and ribavirin as a rescue therapy in difficult-to-treat hepatitis C patients.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31909.
    PubMed         Abstract available

  5. CLIPMAN SJ, Mehta SH, Rodgers MA, Duggal P, et al
    Spatiotemporal phylodynamics of hepatitis C among people who inject drugs in India.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31912.
    PubMed         Abstract available


    J Clin Gastroenterol

  6. WONG RJ, Hubbard A, Bagley L, Shiau R, et al
    Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis: A Systematic Review With Meta-analysis.
    J Clin Gastroenterol. 2021 Apr 9. pii: 00004836-900000000-97439.
    PubMed         Abstract available


    J Infect Dis

  7. HSU YC, Yeh ML, Wong GL, Chen CH, et al
    Incidences and Determinants of Functional Cure during Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
    J Infect Dis. 2021 May 17. pii: 6276897. doi: 10.1093.
    PubMed         Abstract available


    J Viral Hepat

  8. COMBET C, Bhardwaj N, Hedskog C, Podlaha O, et al
    Hepatitis B Virus Genome Diversity in Adolescents: Tenofovir Disoproxil Fumarate Treatment Effect and HBeAg Seroconversion.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13547.
    PubMed         Abstract available

  9. MCDONALD SA, Barclay ST, Innes HA, Fraser A, et al
    Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13543.
    PubMed         Abstract available

  10. NANA J, Skaare K, Bosson JL, Leroy V, et al
    EASL-ALEH 2015 algorithm for the use of transient elastography in treatment-naive patients with Hepatitis B: an independent validation.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13548.
    PubMed         Abstract available

  11. KIM S, Powell J, Naugle J, Ricco M, et al
    Patient-Reported Experiences with Direct Acting Antiviral Therapy in an Integrated Model of Hepatitis C Care in Homeless Shelters.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13544.
    PubMed         Abstract available

  12. LIU PC, Chan C, Huang YH, Chen YJ, et al
    Genetic Variants Associated With Serum Alanine Aminotransferase Levels Among Patients With Hepatitis C Virus Infection: A Genome-Wide Association Study.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13550.
    PubMed         Abstract available

  13. DUFFELL E, Cortez-Pinto H, Simonova M, Dalgard O, et al
    Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545.
    PubMed         Abstract available

  14. OHLENDORF V, Schafer A, Christensen S, Heyne R, et al
    Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting- results from the German Hepatitis C-Registry (DHC-R).
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13546.
    PubMed         Abstract available

  15. SMITH DA, Bradshaw D, Mbisa J, Manso CF, et al
    Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAA Therapy.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13549.
    PubMed         Abstract available

  16. ARSLAN F, Franci G, Nastri BM, Pagliano P, et al
    Hepatitis B virus-induced Hepatocarcinogenesis: A Virological and Oncological Perspective.
    J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13551.
    PubMed         Abstract available


    PLoS One

  17. IREKEOLA AA, Malek NA, Wada Y, Mustaffa N, et al
    Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251673.
    PubMed         Abstract available

  18. BOBARDT M, Ramirez CM, Baum MM, Ure D, et al
    The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance.
    PLoS One. 2021;16:e0251934.
    PubMed         Abstract available


    Vaccine

  19. HAN B, Liu W, Du J, Liu H, et al
    Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00540.
    PubMed         Abstract available

  20. AWAD AM, Ntoso A, Connaire JJ, Hernandez GT, et al
    An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00554.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: